InvestorsHub Logo
Followers 864
Posts 27574
Boards Moderated 1
Alias Born 11/05/2010

Re: None

Monday, 09/10/2012 4:36:23 PM

Monday, September 10, 2012 4:36:23 PM

Post# of 5074
BLRX. BioLineRx Announces Pre-clinical Results Demonstrating the Safety of BL-7010, an Oral Treatment for Celiac Disease and Gluten Sensitivity
- The new safety data, as well as pre-clinical efficacy results, presented at the Better Life for Coeliacs 2012 Conference –
http://finance.yahoo.com/news/biolinerx-announces-pre-clinical-results-110000962.html


Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.